- Solid Tumors
- Pipeline Molecules
- Alliance Partners
Our mission is to provide healthcare professionals with unbiased clinical research information, easily.
Currently, you can access the following clinical trials being conducted worldwide:
Clinicaltrials.gov identifier NCT03942250
Recruitment Status Completed
First Posted May 8, 2019
Last update posted June 27, 2019
To evaluate the effect of human amniotic membrane as a weekly dressing on chronic wounds in Epidermolysis Bullosa (EB) patients.
Dried human amniotic membrane dressing were obtained from National center for radiation research and technology, Egypt (NCRRT), under commercial name REGE pro.
Patients who received REGE pro dressing on EB wounds lesion weekly for 10 weeks
Biological: REGE pro dressing
REGE pro is a dressing of dried human amniotic membrane sterilized by gamma radiation
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, , Learn About Clinical Studies.-->
1- Patients diagnosed as EB wounds must be chronic
1. Patients Must stop other line of treatment
2. Exclude patients have:
1. Autoimmune diseases
Amniotic tissue lab
Egyptian Atomic Energy Authority
Study Director: Nashwa K Radwan, PhD NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY
Lo V, Lara-Corrales I, Stuparich A, Pope E. Amniotic membrane grafting in patients with epidermolysis bullosa with chronic wounds. J Am Acad Dermatol. 2010 Jun;62(6):1038-44. doi: 10.1016/j.jaad.2009.02.048.
Nemr W, Bashandy AS, Araby E, Khamiss O. Biological Activity Alterations of Human Amniotic Membrane Pre and Post Irradiation Tissue Banking. Pak J Biol Sci. 2016;19(7):289-298. doi: 10.3923/pjbs.2016.289.298.